Avoro Capital Advisors LLC boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 11.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,300,000 shares of the biotechnology company’s stock after purchasing an additional 450,000 shares during the quarter. […]
Crosslink Capital Inc. lifted its holdings in shares of Euronet Worldwide, Inc. (NASDAQ:EEFT – Free Report) by 26.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 294,211 shares of the business services provider’s stock after purchasing an additional 61,480 shares during the period. Euronet […]
Advanced Portfolio Management LLC trimmed its holdings in Vodafone Group Public Limited (NASDAQ:VOD – Free Report) by 38.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 275,000 shares of the cell phone carrier’s stock after selling 175,000 shares during the period. […]
Bellevue Group AG reduced its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 6.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 325,776 shares of the biotechnology company’s stock after selling 24,112 shares during the […]
Scout Investments Inc. decreased its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 261,483 shares of the biopharmaceutical company’s stock after selling 4,095 shares during the period. Scout Investments Inc. owned about 0.20% of Halozyme […]